Toxic Accumulation of LPS Pathway Intermediates Underlies the Requirement of LpxH for Growth of Acinetobacter baumannii ATCC 19606

• Daryl L. Richie,

  Affiliation Novartis Institutes for BioMedical Research, Emeryville, CA, United States of America

  ⨯
• Kenneth T. Takeoka,

  Affiliation Novartis Institutes for BioMedical Research, Emeryville, CA, United States of America

  ⨯
• Jade Bojkovic,

  Affiliation Novartis Institutes for BioMedical Research, Emeryville, CA, United States of America

  ⨯
• Louis E. Metzger IV,

  Affiliation Novartis Institutes for BioMedical Research, Emeryville, CA, United States of America

  ⨯
• Christopher M. Rath,

  Affiliation Novartis Institutes for BioMedical Research, Emeryville, CA, United States of America

  ⨯
• William S. Sawyer,

  Affiliation Novartis Institutes for BioMedical Research, Emeryville, CA, United States of America

  ⨯
• Jun-Rong Wei,

  Affiliation Novartis Institutes for BioMedical Research, Emeryville, CA, United States of America

  ⨯
• Charles R. Dean

  * E-mail: charlesr.dean@novartis.com

  Affiliation Novartis Institutes for BioMedical Research, Emeryville, CA, United States of America

  ⨯